EBIT: Income before interest and taxes.
Whitehawk Therapeutics, Inc. (WHWK) had EBIT of $-114.40M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$7.14M |
|
$-20.60M |
|
$0.76M |
|
$6.38M |
|
$121.55M |
|
$-114.40M |
|
$93.80M |
|
$-20.60M |
|
$-107.86M |
|
$-20.60M |
|
$-20.60M |
|
$-20.60M |
|
$-107.86M |
|
|
EBIT |
$-114.40M |
$-115.85M |
|
61.89M |
|
61.89M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$149.01M |
|
$0.00M |
|
$1.82M |
|
$150.83M |
|
$14.52M |
|
-- |
|
-- |
|
$14.52M |
|
$136.31M |
|
$136.31M |
|
$136.31M |
|
47.15M |
|
| Cash Flow Statement Financials | |
$-97.43M |
|
$11.89M |
|
$94.38M |
|
$28.73M |
|
$37.57M |
|
$8.83M |
|
$9.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.36% |
|
-1601.12% |
|
-1601.12% |
|
-1621.39% |
|
-288.26% |
|
-288.26% |
|
$-97.98M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-15.11% |
|
-15.11% |
|
-13.66% |
|
-15.11% |
|
$2.89 |
|
$-1.58 |
|
$-1.57 |
|